#LCSM Chat Topic 03-Jun-2021: Making the Most of #ASCO21

Oncology conferences such as those offered by ASCO (American Society for Clinical Oncology), ESMO (European Society for Medical Oncology), and IASLC (International Association for the Study of Lung Cancer) are premier sources for connecting with others in the  lung cancer community, learning about different aspects of lung cancer research and policy, and highlighting key research results.  The entire lung cancer community can help in disseminating results of research that impacts us.   On Thursday, June 3, at 8 pm Eastern Time (5 pm Pacific), #LCSM Chat will discuss ways the community make… Read More

#LCSM Chat Topic 1-Apr-2021: Tell Us What You Want — We’re Listening

#LCSM Chat began almost eight years ago.  Since then, lung cancer screening, diagnosis, care, and treatment options — as well as social media platforms — have changed dramatically.  The #LCSM Chat team decided it was time to make some changes of our own.   Our first change is a happy announcement:  please join us in welcoming medical oncologist Charu Aggarwal, MD, MPH (@CharuAggarwalMD) to the #LCSM Chat Moderator Team! Charu is the Leslye M. Heisler Associate Professor for Lung Cancer Excellence at Penn Medicine.  Our second change is a survey of #LCSM Chat… Read More

#LCSM Chat 2020-02-06: Dealing with #lungcancer stigma and nihilism

  All too often, lung cancer patients encounter stigma towards their disease and nihilism towards their chances of beating it. Although the causal connection between tobacco smoking and lung cancer was heavily emphasized in well intended public campaigns designed to curb cigarette use, unintended consequences arose. Perhaps more than any other cancer, lung cancer is automatically associated with a bad personal choice – smoking. Many people believe patients could have avoided their lung cancer had they made better decisions. Such perceptions may stifle discussions about lung cancer, cause patients to refuse screening… Read More